Showing results (1191-1200 of 1,204) with videos related to

Sort By:
Pageof 121
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 25, 2014
Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control ConsortiumC Bosetti, V Rosato, D Li, et al.
Cancers|July 1, 2020
Recommendations for Implementing Lung Cancer Screening with Low-Dose Computed Tomography in EuropeGiulia Veronesi, David R Baldwin, Claudia I Henschke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2022
Six-Year Results From RELEVANCE: Lenalidomide Plus Rituximab (R2) Versus Rituximab-Chemotherapy Followed by Rituximab Maintenance in Untreated Advanced Follicular LymphomaFranck Morschhauser, Loretta Nastoupil, Pierre Feugier, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|December 15, 2025
Adverse outcomes among pregnant women with COVID-19 according to hospitalization status: A prospective individual participant data meta-analysis in Europe and North AmericaOdette de Bruin, Emeline Maisonneuve, Eimir Hurley, et al.
Scandinavian Journal of Primary Health Care|January 26, 2018
Burden of cardiovascular disease across 29 countries and GPs' decision to treat hypertension in oldest-oldSven Streit, Jacobijn Gussekloo, Robert A Burman, et al.
Pharmacoepidemiology and Drug Safety|December 26, 2025
Medications Used Among Nonhospitalized Pregnant Women With COVID-19: A Prospective Individual Patient Data Meta-Analysis in Europe and North AmericaOdette de Bruin, Emeline Maisonneuve, Eimir Hurley, et al.
Journal of General Internal Medicine|January 18, 2019
Patient Characteristics and General Practitioners' Advice to Stop Statins in Oldest-Old Patients: a Survey Study Across 30 CountriesMilly A van der Ploeg, Sven Streit, Wilco P Achterberg, et al.
Leukemia|January 23, 2021
Long-term outcome of imatinib 400 mg compared to imatinib 600 mg or imatinib 400 mg daily in combination with cytarabine or pegylated interferon alpha 2a for chronic myeloid leukaemia: results from the French SPIRIT phase III randomised trialFrancois Guilhot, Françoise Rigal-Huguet, Joëlle Guilhot, et al.
The Lancet. Child & Adolescent Health|March 16, 2019
MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohortCristina Pellegrini, Francesca Botta, Daniela Massi, et al.
Journal of Neurology|April 23, 2014
Rate of intravenous thrombolysis for acute ischaemic stroke in the North-of-France region and evolution over timeN Dequatre-Ponchelle, H Touzani, A Banh, et al.
Pageof 121